SARS-CoV-2 population-based seroprevalence studies in Europe: a scoping review

Review of 23 studies found seroprevalence ranged from 0.42% to 13.6% (latter in area of high transmission) among 12 general population studies, from 0.91% to 23.3% in 8 blood donor studies, and 0.5% to 10.2% in 3 studies recruiting individuals through employment.

Source:

BMJ Open